home / stock / smlr / smlr news


SMLR News and Press, Semler Scientific Inc From 05/03/22

Stock Information

Company Name: Semler Scientific Inc
Stock Symbol: SMLR
Market: OTC
Website: semlerscientific.com

Menu

SMLR SMLR Quote SMLR Short SMLR News SMLR Articles SMLR Message Board
Get SMLR Alerts

News, Short Squeeze, Breakout and More Instantly...

SMLR - Why Semler Scientific Stock Is Sinking Today

Shares of Semler Scientific (NASDAQ: SMLR) were sinking 23.1% as of 10:33 a.m. ET on Tuesday. The steep decline came after the medical technology company reported its first-quarter results following the market close on Monday. Semler announced Q1 revenue of $14 million, up 6% ye...

SMLR - Sonoma, XORTX top healthcare gainers; Spero, Semler Scientific lead losers' pack

Gainers: Sonoma Pharmaceuticals (SNOA) +42%. XORTX Therapeutics (XRTX) +18%. Retractable Technologies (RVP) +14%. Catalent (CTLT) +12%. Field Trip Health (FTRP) +5%. Losers: Spero Therapeutics (SPRO) -61%. Semler Scientific (SMLR) -23%. Galmed Pharmaceu...

SMLR - Semler Scientific, Inc. (SMLR) CEO Douglas Murphy-Chutorian on Q1 2022 Results - Earnings Call Transcript

Semler Scientific, Inc. (SMLR) Q1 2022 Earnings Conference Call May 02, 2022, 10:30 AM ET Company Participants Douglas Murphy-Chutorian - CEO Dennis Rosenberg - Chief Marketing Officer Andrew Weinstein - SVP, Finance and Accounting Conference Call Participants Brooks O’Neil - Lake Stre...

SMLR - Semler Scientific down 10% following Q1 bottom and top line misses

Shares of Semler Scientific (NASDAQ:SMLR) dropped 10% in post-market trading after the healthcare technology products company reported Q1 2021 earnings that missed on the top and bottom lines. Q1 GAAP EPS of $0.41 missed by $0.07 while revenue of ~$14M, a 6.2% year-over-ye...

SMLR - Semler Scientific GAAP EPS of $0.41, revenue of $14.02M

Semler Scientific (NASDAQ:SMLR): Q1 GAAP EPS of $0.41 Revenue of $14.02M (+6.2% Y/Y) Up to $20.0M stock buyback program initiated Q2 revenue will range from $14.2M-15.2M FY22 revenue will range from $58.0M-60.0M Shares +3.09%. Source: press release For further details see: Semler S...

SMLR - Semler Reports First Quarter 2022 Financial Results

Semler Reports First Quarter 2022 Financial Results PR Newswire 2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.0 million , an increase of $0.8 million , or 6%, compared to $13.2 million Net income was $3...

SMLR - Semler Scientific: A Small Company Solving A Big Problem

Semler Scientific has been sold off since its Q3 and Q4 earnings misses, down 67% from November 2021 levels. Semler is tackling massive healthcare problems such as PAD, diabetes, and Alzheimer's. Its flagship QuantaFlo product is a fundamentally superior product that tests for PAD...

SMLR - Semler to Report First Quarter 2022 Financial Results and Host Conference Call on May 2, 2022

Semler to Report First Quarter 2022 Financial Results and Host Conference Call on May 2, 2022 PR Newswire SANTA CLARA, Calif. , April 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve ...

SMLR - Semler Scientific (SMLR) Investor Presentation -Slideshow

The following slide deck was published by Semler Scientific, Inc. in conjunction with this event. For further details see: Semler Scientific (SMLR) Investor Presentation -Slideshow

SMLR - Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference

Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference PR Newswire SANTA CLARA, Calif. , April 7, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical eff...

Previous 10 Next 10